AnaptysBio
ANAB
#4829
Rank
A$2.56 B
Marketcap
A$89.07
Share price
-3.64%
Change (1 day)
227.93%
Change (1 year)

AnaptysBio (ANAB) - Total debt

Total debt on the balance sheet as of December 2025 : A$20.15 Million

According to AnaptysBio's latest financial reports the company's total debt is A$20.15 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

AnaptysBio - Total debt on balance sheet (from 2014 to 2025)

Total debt by year

Year Total debt Change
2025-12-31A$21.06 M-18.28%
2024-12-31A$25.78 M-1.39%
2023-12-31A$26.14 M-8.52%
2022-12-31A$28.58 M-1.12%
2021-12-31A$28.9 M6398.63%
2020-12-31A$0.44 M-89.26%
2019-12-31A$4.14 M-61.77%
2018-12-31A$10.83 M-41.45%
2017-12-31A$18.5 M-3.42%
2016-12-31A$19.15 M183.45%
2015-12-31A$6.75 M12.39%
2014-12-31A$6.01 M475.6%
2013-12-31A$1.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
A$4.71 M-76.61%๐Ÿ‡บ๐Ÿ‡ธ USA